Metabolic & weight
The incretin class. The best-evidenced corner of the peptide world, and where the gap between the trial dose and the internet dose is widest.
3 posts
The most thoroughly studied peptide in consumer circulation, and the one where the gap between the trial dose and the internet dose is widest.
Adds a second incretin receptor to the same basic idea, and the extra pathway shows up clearly in the trial results.
The most talked-about unapproved peptide in the world, on the strength of a mid-stage trial and very little else.